Efficacy and Safety of Combination Therapy of Natural Human Interferon Beta and Ribavirin in Chronic Hepatitis C Patients with Genotype 1b and High Virus Load-Reference-Cited by-同舟云学术

Efficacy and Safety of Combination Therapy of Natural Human Interferon Beta and Ribavirin in Chronic Hepatitis C Patients with Genotype 1b and High Virus Load

Published:2010 Issue:11 Volume:49 Page:957-963
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Arase Yasuji¹,Suzuki Fumitaka¹,Akuta Norio¹,Sezaki Hitomi¹,Suzuki Yoshiyuki¹,Kawamura Yusuke¹,Kobayashi Masahiro¹,Hosaka Tetsuya¹,Yatsuji Hiromi¹,Hirakawa Miharu¹,Saito Satoshi¹,Ikeda Kenji¹,Kobayashi Mariko²,Kumada Hiromitsu¹

Affiliation:

1. Department of Hepatology and Okinaka Memorial Institute for Medical Research, Toranomon Hospital

2. Hepatic Research Unit, Toranomon Hospital

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/49/11/49_11_957/_pdf

Reference23 articles.

1. 1. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358: 958-965, 2001.

2. 2. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347: 975-982, 2002.

3. 3. Hadziyannis SJ, Sette H, Morgan TR, et al. PEGASYS International Study Group. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 140: 346-355, 2004.

4. 4. McHutchison JG, Manns M, Patel K, et al. Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C. Gastroenterology 123: 1061-1069, 2002.

5. 5. Shiffman ML, Di Bisceglie AM, Lindsay KL, et al. Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial Group. Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment. Gastroenterology 126: 1015-1023, 2004.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of telaprevir with natural human interferon-β and ribavirin in Japanese chronic hepatitis C patients with depression;Hepatology Research;2017-07-19

2. Natural interferon-beta treatment for patients with chronic hepatitis C in Japan;World Journal of Hepatology;2015

3. Successful natural interferon-β plus ribavirin therapy in a chronic hepatitis C patient after discontinuation of interferon-α treatment due to arrhythmia and interstitial pneumonia;Clinical Journal of Gastroenterology;2014-06-06

4. Combination therapy of natural human interferon-beta and ribavirin for chronic hepatitis C patients with injection drug use;Hepatology Research;2013-03-27

5. Natural interferon-beta plus ribavirin therapy led to sustained virological response after seven unsuccessful courses of anti-viral treatment in a chronic hepatitis C patient;Clinical Journal of Gastroenterology;2013-02-17